Keyphrases
Amitriptyline
100%
Indonesia
72%
Pain Intensity
64%
Chronic Low Back Pain (cLBP)
54%
Clinical Survey
50%
Chronic Nonspecific Low Back Pain
50%
Headache Attacks
50%
Acetaminophen
50%
Intelligence Level
50%
Comorbidity
50%
Geriatric Patients
50%
S100
50%
Adjuvant Therapy
50%
Tension-type Headache
50%
Pain Reduction
50%
Green Tea Extract
50%
Epilepsy Patients
50%
Hospital-based
50%
Thrombolysis
50%
Diagnostic Test
50%
Acute Ischemic Stroke
50%
Effectiveness Comparison
50%
Magnetic Resonance Imaging
50%
Epilepsy
50%
Lumbar Vertebrae
50%
Valproic Acid
50%
Headache
42%
Intervention Group
40%
Raven's Progressive Matrices
37%
Plain Image
30%
Lumbosacral
30%
Modified Rankin Scale
30%
Inclusion Criteria
27%
Negative Impact
25%
Surabaya
22%
National Institutes of Health Stroke Scale (NIHSS)
20%
High Sensitivity
20%
Low Back Pain
19%
No Significant Difference
18%
Disability
17%
Pain Location
15%
Double-blind Randomized Controlled Trial
14%
Matrix Test
12%
Intelligence Tests
12%
General Hospital
12%
Value Loss
12%
Antiepileptic Drugs
12%
Motoric
12%
Loss Function
12%
Patient Well-being
12%
Pharmacology, Toxicology and Pharmaceutical Science
Low Back Pain
100%
Amitriptyline
100%
Brain Ischemia
100%
Paracetamol
50%
Disability
50%
Tension Headache
50%
Sinecatechins
50%
Sodium Valproate
50%
Headache
50%
Comorbidity
50%
Neuron Specific Enolase
50%
Camellia Sinensis
50%
Placebo
43%
Cerebrovascular Accident
32%
Rankin Scale
30%
Randomized Controlled Trial
14%
Cross-Sectional Study
13%
Non Communicable Disease
12%
Neuroprotection
12%
Antioxidant
10%
Inflammation
10%
Hypoxia
10%
Anti-Inflammation
10%
Ischemia
10%
Interleukin 10
10%
Analgesic Agent
9%
Treatment Group
9%
Musculoskeletal Disease
8%
Cognitive Defect
6%
Anticonvulsive Agent
6%
Chronic Pain
5%
Randomized Clinical Trial
5%
Drug Administration
5%
Diseases
5%
Nursing and Health Professions
Amitriptyline
100%
Low Back Pain
100%
Pain Intensity
60%
Tylenol
50%
Tension Headache
50%
Headache
50%
Valproic Acid
50%
Nuclear Magnetic Resonance Imaging
50%
Diagnostic Test
50%
Placebo
18%
Contraindication
16%
Analgesic Agent
9%
Antidepressant
9%
Treatment Group
9%
Pacemaker
8%
Neurosurgery
8%
Cross-Sectional Study
8%
Teaching Hospital
8%
Sensitivity and Specificity
8%
Musculoskeletal Disease
8%
Drug Administration
5%
Prophylaxis
5%
